Press Telegraph noted that three out of five analysts rated Tokai Pharmaceuticals Inc. (Nasdaq: TKAI) a Buy while two rated the company a Hold. The stock price soared 26 cents to close at $1.28.
Positive ratings for Tokai
September 15, 2016 at 17:17 PM EDT